Chemed Corporation reiterates earnings guidance for full year 2024. For the full year, company reiterates earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, guidance range of $23.30 to $23.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
572.7 USD | -1.32% | +0.83% | -2.06% |
26/04 | Chemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer Says | MT |
25/04 | Transcript : Chemed Corporation, Q1 2024 Earnings Call, Apr 25, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.06% | 8.75B | |
+14.31% | 82.36B | |
-30.46% | 69.97B | |
+11.55% | 29.41B | |
+1.46% | 17.08B | |
-11.30% | 16.99B | |
-1.26% | 15.21B | |
+2.64% | 13.25B | |
+62.55% | 12.12B | |
+29.68% | 12.08B |
- Stock Market
- Equities
- CHE Stock
- News Chemed Corporation
- Chemed Corporation Reiterates Earnings Guidance for Full Year 2024